Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients
Julie A. Stortz,Juan C. Mira,Steven L. Raymond,Tyler J. Loftus,Tezcan Ozrazgat-Baslanti,Zhongkai Wang,Gabriela L. Ghita,Christiaan Leeuwenburgh,Mark S. Segal,Azra Bihorac,Babette A. Brumback,Alicia M. Mohr,Philip A. Efron,Lyle L. Moldawer,Frederick A. Moore,Scott C. Brakenridge,Brakenridge, Scott C.,Leeuwenburgh, Christiaan,Stortz, Julie A.,Brumback, Babette A.,Mira, Juan C.,Ozrazgat-Baslanti, Tezcan,Ghita, Gabriela L.,Moore, Frederick A.,Bihorac, Azra,Wang, Zhongkai,Mohr, Alicia M.,Moldawer, Lyle L.,Segal, Mark S.,Raymond, Steven L.,Loftus, Tyler J.,Efron, Philip A.
DOI: https://doi.org/10.1097/TA.0000000000001758
2019-10-03
Journal of Trauma and Acute Care Surgery
Abstract:BACKGROUND
A growing number of patients survive sepsis but remain chronically critically ill. We sought to define clinical outcomes and incidence of chronic critical illness (CCI) after sepsis and to determine whether selected biomarkers of inflammation, immunosuppression, and catabolism differ between these patients and those that rapidly recover (RAP).
METHODS
This 3-year prospective observational cohort study (NCT02276417) evaluated 145 surgical intensive care unit patients with sepsis for the development of CCI (≥14 days of intensive care unit resource utilization with persistent organ dysfunction). Patient clinical demographics, outcomes, and serial serum/urine samples were collected for plasma protein and urinary metabolite analyses.
RESULTS
Of 145 sepsis patients enrolled, 19 (13%) died during their hospitalization and 71 (49%) developed CCI. The CCI patients were significantly older (mean, 63 ± 15 vs. 58 ± 13 years, p = 0.006) and more likely to be discharged to long-term acute care facilities (32% vs. 3%, p < 0.0001), whereas those with RAP were more often discharged to home or a rehabilitation facility. Six-month mortality was significantly higher in CCI as compared with RAP cohort (37% vs. 2%; p 48 hours after admission; odds ratio [OR], 10.93; 95% confidence interval [CI], 4.15–28.82]), interfacility transfer (OR, 3.58; 95% CI, 1.43–8.96), vasopressor-dependent septic shock (OR, 3.75; 95% CI, 1.47–9.54), and Sequential Organ Failure Assessment score of 5 or greater at 72 hours (OR, 5.03; 95% CI, 2.00–12.62) as independent risk factors for the development of CCI. The CCI patients also demonstrated greater elevations in inflammatory cytokines (IL-6, IL-8, IL-10), and biomarker profiles are consistent with persistent immunosuppression (absolute lymphocyte count and soluble programmed death ligand 1) and catabolism (plasma insulin-like growth factor binding protein 3 and urinary 3-methylhistidine excretion).
CONCLUSION
The development of CCI has become the predominant clinical trajectory in critically ill surgical patients with sepsis. These patients exhibit biomarker profiles consistent with an immunocatabolic phenotype of persistent inflammation, immunosuppression, and catabolism.
LEVEL OF EVIDENCE
Prognostic, level II.
surgery,critical care medicine